Miguel Virseda-Chamorro | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Miguel Virseda-Chamorro | Medicine and Dentistry | Best Researcher Award

Dr. Miguel Virseda-Chamorro, Hospital Nacional de parapléjicos, Spain

Dr. Miguel Virseda-Chamorro is a distinguished urologist with extensive expertise in urodynamics and pelvic floor disorders. He earned his MD from the University of Valencia in 1981 and specialized in Urology at Gómez Ulla Hospital in 1990. He holds a PhD, awarded cum laude in 1992, and completed further education in Health Sciences Statistics. Dr. Virseda is a Fellow of the European Board of Urology and has contributed to major scientific journals. Recognized with several prestigious awards, his research has impacted functional urology and neurogenic bladder treatment. He is fluent in multiple languages and an active member of several urological societies. 🏥🧬📊

Publication Profile

Scopus

Orcid

Academic Formation and Specializations

Dr. Virseda-Chamorro has an impressive academic trajectory, beginning with a Licenciatura in Medicine and Surgery from the University of Valencia (1981) and multiple specialized courses in Urology and Medical Aeronautics. He has also pursued advanced degrees, including a Master in Health Sciences Design and Statistics (2001), which supports his clinical research. His PhD in Urology, awarded with distinction, further underscores his expertise in the field.

Awards and Distinctions

His outstanding contributions have been recognized through several prestigious awards, such as the Best Doctoral Thesis Awards (1992, 1995), and multiple honors from the Spanish Urology Association for his groundbreaking research. These recognitions validate his impact on the field of urology, particularly in areas like urodynamic models and pelvic prolapse treatment.

Teaching and Clinical Trials

Dr. Virseda-Chamorro has also made significant contributions to medical education, leading various courses on pelvic floor treatment and urodynamic pediatric pathologies. His participation in numerous clinical trials, such as evaluating the efficacy of beta-3 agonists for overactive bladder, shows his ongoing commitment to advancing medical knowledge and patient care.

Conclusion

Dr. Miguel Virseda-Chamorro’s rich academic background, clinical expertise, significant research contributions, and numerous honors make him an ideal candidate for the Best Researcher Award. His dedication to both clinical practice and advancing scientific understanding in urology highlights his qualification for this prestigious recognition.

 

Publication Top Notes

  • Can We Differentiate Between Organic and Functional Bladder Outlet Obstruction in Males With Parkinson’s Disease? (2024)  🧠📅
  • Factors Influencing Postoperative Overactive Bladder after Adjustable Trans-Obturator Male System Implantation for Male Stress Incontinence following Prostatectomy (2023) – 1 citation 💉📅
  • Update on Adjustable Trans-Obturator Male System (ATOMS) for Male Incontinence after Prostate Cancer Surgery (2023) – 4 citations 🦠📅
  • ATOMS in Patients with Post-Prostatectomy Incontinence and Previously Treated Urethral Stricture or Bladder Neck Contracture (2022) – 6 citations 🚻📅
  • Functional Changes during the Voiding Phase in Men with Non-Neurogenic Detrusor Underactivity Undergoing Bladder Catheterization (2022)  🧬📅
  • Compression or Obstruction: Analysis of the Function of ATOMS Based on Pre- and Postoperative Urodynamic Data (2022) – 4 citations 🛠️📅
  • Urodynamics of Urinary Retention in Guillain-Barré Syndrome Post-Infection by SARS-CoV-2 (2022) – 1 citation 🌐📅
  • Influence of ATOMS Implant on the Voiding Phase of Patients with Post-Prostatectomy Urinary Incontinence (2022) – 3 citations 🚽📅
  • Prevalence and Risk Factors for Lower Urinary Tract Symptoms after Robotic Sacrocolpopexy (2021) – 🤖📅
  • Long-term Outcome of ATOMS for Stress Urinary Incontinence in the Iberian Multicentre Study (2020) – 17 citations 📊📅

 

 

 

 

Carmen Lefaucheur | Dentistry Award | Excellence in Research

Posted on by ScienceFather

Prof Dr. Carmen Lefaucheur | Dentistry Award | Excellence in Research

Prof Dr. Carmen Lefaucheur, Hopital Saint Louis, France

Prof. Dr. Carmen Lefaucheur is a highly accomplished nephrologist and expert in kidney transplantation. She serves as the Head of the Department of Nephrology and Kidney Transplantation at Saint-Louis Hospital, Paris, and is a Professor of Nephrology at Université Paris Cité. Additionally, she is the Medical Director of the Paris Institute for Transplantation & Organ Regeneration (PITOR) and has an extensive background in personalized medicine for chronic diseases and organ transplantation. She holds multiple prestigious positions in international scientific committees and has received numerous awards, including the Paul I. Terasaki Clinical Science Award.

 

Publication profile

Orcid


Research Leadership:

Dr. Lefaucheur is the Head of the Department of Nephrology and Kidney Transplantation at Saint-Louis Hospital and the Medical Director of the Paris Institute for Transplantation & Organ Regeneration (PITOR). Her leadership in these roles highlights her impact in advancing research and clinical practice in nephrology and transplantation.

Research Excellence:

She has received numerous prestigious awards, including the Paul I. Terasaki Clinical Science Award and the European Society of Organ Transplantation Award, recognizing her contributions to the field. Her research publications are highly cited, with significant papers in top-tier journals such as Nature Medicine.

Grant Leadership:

Dr. Lefaucheur coordinates major research grants, including the RO1 Grant for biomarkers and digital pathology, indicating her pivotal role in funding and leading cutting-edge research.

International Influence:

Her extensive involvement with international committees and scientific societies, such as the European Society of Organ Transplantation (ESOT) and the American Society of Transplantation (AST), demonstrates her influence and recognition in the global research community.

Educational Contributions:

Her roles in organizing scientific meetings and her invitations to speak at major international congresses further underline her leadership and expertise.

Publication Top Notes

Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment

From Humoral Theory to Performant Risk Stratification in Kidney Transplantation

Conclusion

Dr. Lefaucheur embodies the qualities of excellence in research and would be a strong candidate for this award.

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Dr Cristina Papayannidis, IRCCS, Azienda Ospedaliero Universitaria S.Orsola Malpighi, Bologna, Italy, Italy

Dr. Cristina Papayannidis appears to be an outstanding candidate for the Best Researcher Award based on several key criteria:

Publication profile

scopus

Extensive Experience

Dr. Papayannidis has been deeply involved in clinical research and patient care in hematology since her early career. Her role as Dirigente Medico Ematologia at IRCCS Azienda Ospedaliero Universitaria di Bologna highlights her leadership in AML and ALL clinical trials.

High Research Output

She has authored over 130 publications and has been a principal or sub-investigator in more than 60 phase 1-3 clinical trials, showcasing her significant contributions to advancing hematology research.

Recognition and Influence

With an H-index of 34, she has made substantial impacts in her field. Her role as a speaker at over 300 national and international events, including prestigious conferences like ASH and EHA, underscores her influential presence in the hematological community.

Mentorship and Leadership

Her positions as a mentor in EHA Master Classes and member of various working groups demonstrate her commitment to guiding the next generation of researchers and shaping the future of hematology.

Professional Memberships

  1. Memberships in esteemed organizations such as SIE, EHA, and AACR, and her role on the Hematological Malignancies Committee ESMO further reflect her prominent status and active participation in the scientific community.

Dr. Papayannidis’s extensive research experience, high publication volume, significant impact on clinical practice, and active involvement in mentorship and professional societies make her a highly suitable candidate for the Best Researcher Award.

 

Research focus
The research focus of the individuals associated with these articles centers on hematological malignancies and their management. They investigate advanced treatments and strategies for diseases like acute lymphoblastic leukemia (ALL), particularly in the context of drug therapies and stem cell transplantation. Key topics include evaluating the efficacy of ponatinib versus imatinib in treating Philadelphia chromosome-positive ALL, using ponatinib to prevent relapse after transplantation, and assessing the impact of inotuzumab ozogamicin on outcomes and complications in refractory cases. Their work contributes to improving therapeutic approaches and patient outcomes in hematology. 🩺💉🔬

Publication top notes

Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)

Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission †

Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease